The study had no commercial funding, and the researchers report no conflicts of interest.
Reference
- Ong MS, Rothman D, Barmettler S, et al. New-onset hypogammaglobulinemia and infectious complications associated with rituximab use in childhood-onset rheumatic diseases. Rheumatology (Oxford). 2021 Jul 30;keab626. Online ahead of print.